Skip to main content
OpenTrials

Clinical trial condition

Breast Diseases

Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.

10,352 public trials 1,986 recruiting studies
Refine in advanced search Browse all conditions

Breast Diseases trial results

Active, Not Recruiting

A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors

NCT06157892

Conditions
Advanced Breast Cancer, Advanced Gastric Cancer, Breast Diseases, +17 more
Locations
  • Banner-University Medical Center Tucson Campus Tucson, Arizona, United States
  • Banner-University Medical Center Tucson Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Pharmacy, Attn: Kelly Myrdal Tucson, Arizona, United States
  • University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
View all 135 locations
View Trial Details
Active, Not Recruiting

Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer

NCT03546686

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • Ohio State University Medical Center Columbus, Ohio, United States
  • Providence Cancer Institute Portland, Oregon, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

NCT04975308

Conditions
Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, +7 more
Locations
  • Ironwood Cancer & Research Centers Chandler, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Marin Cancer Care Greenbrae, California, United States
  • University of California Davis (UC Davis) Comprehensive Cancer Center Sacramento, California, United States
View all 243 locations
View Trial Details
Active, Not Recruiting

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

NCT04521686

Conditions
Adenocarcinoma, Any Solid Tumor, Astrocytoma, +49 more
Locations
  • Mayo Clinic of Scottsdale Phoenix, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • USC Norris Cancer Hospital Los Angeles, California, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
View all 33 locations
View Trial Details
Active, Not Recruiting

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

NCT04549207

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • William Osler Health System Brampton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Southlake Regional Health Centre Newmarket, Ontario, Canada
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
View Trial Details
Active, Not Recruiting

Endocrine Therapy-Induced Alopecia in Postmenopausal and Premenopausal Female Breast Cancer Patients

NCT05612100

Conditions
Breast Carcinoma, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Mayo Clinic Health System in Albert Lea Albert Lea, Minnesota, United States
  • Essentia Health Baxter Clinic Baxter, Minnesota, United States
  • Sanford Joe Lueken Cancer Center Bemidji, Minnesota, United States
  • Essentia Health Saint Joseph's Medical Center Brainerd, Minnesota, United States
View all 23 locations
View Trial Details

Related conditions